Additional file 7 of Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study

Additional file 7. Median AE-QoL and HAE-QoL score at different time points during the 88-week extension period, all C1-INH(SC) doses combined (US only).